Quick Answer
Zomedica Corp. reported Total Revenue of $32.03 million for fiscal year 2025.
Zomedica Corp. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $32.03M | +17.4% |
| 2024 | $27.29M | +8.3% |
| 2023 | $25.19M | +33.0% |
| 2022 | $18.93M | +358.0% |
| 2021 | $4.13M | — |
| 2020 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.10M | +15.7% | +16.2% |
| June 30, 2025 | $6.96M | +13.6% | +7.1% |
| March 31, 2025 | $6.50M | +3.8% | -7.1% |
| September 30, 2024 | $7.00M | +10.2% | +14.1% |
| June 30, 2024 | $6.13M | +1.8% | -2.1% |
| March 31, 2024 | $6.26M | +14.2% | -1.3% |
| September 30, 2023 | $6.35M | +32.9% | +5.4% |
| June 30, 2023 | $6.02M | +41.8% | +9.8% |
- Zomedica Corp. showed an increase of +17.4% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Zomedica Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: